U.S., March 14 -- ClinicalTrials.gov registry received information related to the study (NCT06873698) titled 'A Pilot Study of Neurobehavioral Therapy for Functional Neurological Disorder' on March 07.
Brief Summary: The study aims to enroll 40 participants at Rhode Island Hospital. 20 participants with Motor Functional Neurological Disorder (mFND) will be randomized to Neurobehavioral Therapy (Group 1) and 20 participants with mFND to Standard Medical Care (Group 2). Those randomized to neurobehavioral therapy will be asked to complete treatment sessions over the course of 12 to 18 weeks. Those in the standard medical care arm will continue to receive their routine care with their clinicians.
All participants regardless of group assignme...